Effects of Royal Jelly Supplementation in Chronic Kidney Disease

Launched by UNIVERSIDADE FEDERAL FLUMINENSE · May 27, 2024

Keywords

ClinConnect Summary

This clinical trial is studying the effects of royal jelly, a natural substance made by bees, on patients with chronic kidney disease (CKD) who are on hemodialysis (a treatment that helps filter waste from the blood when the kidneys aren't working well). The researchers want to see if royal jelly can help reduce inflammation and slow down the aging of cells in these patients.

To be eligible for this study, participants need to be between 65 and 75 years old, have been receiving hemodialysis for at least six months, and use a specific type of access called an arteriovenous fistula (AVF) for their treatment. However, individuals who are pregnant, breastfeeding, smokers, or who have certain medical conditions like cancer or infections cannot participate. If you join the trial, you can expect to take royal jelly supplements and be monitored for any changes in your health related to inflammation and cell aging. This study is currently looking for participants, so it's a great opportunity for those who qualify to potentially benefit from this natural supplement.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • patients with CKD undergoing hemodialysis for more than 6 months
• • patients with arteriovenous fistula (AVF) as vascular access.
• Exclusion Criteria:
• • pregnant,
• • lactating,
• • smoker
• • patients using antibiotics and antioxidant supplements in the last three months
• • patients with autoimmune and infectious diseases,
• • patients with cancer, liver disease, and AIDS